August 11, 2021 - fortworthtx.gov -

The Dallas-Fort Worth High-Speed Transportation Connections Study is moving into its second phase of analysis. The Regional Transportation Council recently approved the study’s Phase 1 recommendations.

The current study is evaluating high-speed transportation alternatives to modernize and enhance mobility between Dallas and Fort Worth. The RTC adopted a high-speed corridor policy, which gave staff the go-ahead to proceed with the Phase 1 recommendations, coordinate with federal partners on environmental requirements and integrate alignment and mode recommendations into other planning activities.

Having met the Phase 1 goals of identifying technology modes and alignments, two modes are proposed to be carried forward: high-speed rail and hyperloop. Forty-three alignments were studied in the 230-square-mile study area, and a route in the I-30 corridor with a few options for navigating major highway interchanges is recommended to move into Phase 2.

The addition of high-speed transportation alternatives would accommodate the current growth and provide residents with safe, reliable and efficient travel. The final recommended solution will connect to local transportation systems and could link the region to future high-speed services.

The North Central Texas Council of Government’s Metropolitan Transportation Plan, Mobility 2045, includes high-speed transportation between Dallas and Fort Worth as a future transportation choice, to accommodate an expected population exceeding 11 million by 2045.

The purpose of Phase 2 is to gain federal environmental approval of the preferred alignment and technology for the project. This includes conceptual and preliminary engineering, financial and project management plans.

The National Environmental Policy Act requires detailed studies of all aspects of the study area, including all potential social, biological and cultural impacts, both positive and adverse.

Four open houses in the study area are being planned for late September and October to provide an overview of Phase 1 recommendations.